Usefulness of long-acting Ca antagonist in hypertensive patients with metabolic syndrome
Takishita, S.
Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 9): 607-610
2006
ISSN/ISBN: 0047-1852 PMID: 17458290 Document Number: 602512
Document emailed within 1 workday
Related Documents
Ishida, A.; Ohya, Y. 2011: The usefulness of long-acting calcium channel blocker for hypertensive patients with metabolic syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 1): 582-586Liao, P.-A.; Pan, S.-W.; Chen, C.-Y.; Deng, C.-Y.; Dong, Y.-H. 2023: Prescription Patterns of new use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting β2 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting β2 Agonists Plus Inhaled Corticosteroids International Journal of Chronic Obstructive Pulmonary Disease 18: 553-563
Limpawattana, P.; Sawanyawisuth, K.; Busaracome, P.; Foocharoen, C.; Phitsanuwong, C.; Chumjan, S.; Chotmongkol, R.; Chaisuksant, S. 2008: The best criteria to diagnose metabolic syndrome in hypertensive Thai patients Journal of the Medical Association of Thailand 91(4): 485-490
Nayler, W.G.; Gu, X.H. 1991: The unique binding properties of amlodipine: a long-acting calcium antagonist Journal of Human Hypertension 5(Suppl 1): 55-59
Medvedev, I.N.; Gromnatskiĭ, N.I.; Volobuev, I.V.; Osipova, V.M.; Dement'ev, V.I.; Storozhenko, M.V. 2004: Thrombocytic hemostasis in hypertensive patients with metabolic syndrome and its correction with lovastatin Klinicheskaia Meditsina 82(10): 37-41
Escudero, J.; Hernandez, H. 1991: Clinical evaluation of amlodipine, a new long-acting calcium antagonist, in mild and moderate hypertension International Journal of Clinical Pharmacology Research 11(5): 243-246
Knight, J.R.; Ponce de León, O. 1986: Usefulness of the ergometric testing in patients with the long Q-T syndrome Cor et Vasa 28(3): 201-205
Runikhina, N.K.; Tkacheva, O.N. 2008: Efficacy of long acting calcium antagonist felodipine in smoking women with essential arterial hypertension Kardiologiia 48(9): 50-52
Katz, L.B.; Scott, C.K.; Shriver, D.A. 1986: Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidine Journal of Pharmacology and Experimental Therapeutics 238(2): 587-593
Bespalova, I.D.; Kaliuzhin, V.V.; Riazantseva, N.V.; Mediantsev, I.A.; Osikhov, I.A.; Murashev, B.I. 2013: Pleiotropic effects of atorvastatin and dynamics of quality of life characteristics in patients with hypertensive disease and metabolic syndrome Klinicheskaia Meditsina 91(12): 46-50
Inagaki, A. 2016: Safety of Long-acting Injectable Antipsychotics Is Long-acting Injection a High-risk Treatment Option? Seishin Shinkeigaku Zasshi 118(8): 589-597
Pasternak, G.W.; Childers, S.R.; Snyder, S.H. 1980: Naloxazone, a long-acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro Journal of Pharmacology and Experimental Therapeutics 214(3): 455-462
Belsey, E.M. 1991: Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Task Force on Long-Acting Systemic Agents for Fertility Regulation Advances in contraception: the official journal of the Society for the Advancement of Contraception 7(2-3): 257-270
Belsey, E.M. 1991: Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Task Force on Long-Acting Systemic Agents for Fertility Regulation Advances in contraception: the official journal of the Society for the Advancement of Contraception 7(2-3): 257-270
Ding, Y.A.; Chou, T.C.; Lin, K.C. 1994: Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension Journal of Human Hypertension 8(4): 273-278
Tsuchihashi, T. 2006: Usefulness of diuretics for hypertensive patients Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 6): 281-284
Wintrob, R.M. 1970: Long acting phenothiazines and long term psychotic patients: the role of fluphenazine enanthate in treatment Diseases of the Nervous System 31(Suppl): 50-62
Marchi, S.D.; Prior, M.; Zannoni, M.; Lucchese, L.; Arosio, E. 1999: Effects of an angiotensin Ii receptor antagonist (valsartan) on macro- and microcirculatory hemodynamics of the arm in hypertensive patients Minerva Cardioangiologica 47(12): 554-556
Biausque, F.; Willoteaux, S.; Beregi, J.P.; Devos, P.; Deklunder, G.; Mounier-Vehier, C. 2006: Usefulness of magnetic resonance angiography in the screening of renal artery stenosis in hypertensive patients: proposition of a diagnostic algorithm: a study of 245 patients Archives des Maladies du Coeur et des Vaisseaux 99(7-8): 705-711
Herzog, J.L.; Solomon, J.A.; Draelos, Z.; Fleischer, A.; Stough, D.; Wolf, D.I.; Abramovits, W.; Werschler, W.; Green, E.; Duffy, M.; Rothaul, A.; Tansley, R. 2011: A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis Journal of Drugs in Dermatology: Jdd 10(8): 853-860